Fecal amine metabolite analysis before onset of severe necrotizing enterocolitis in preterm infants: a prospective case–control study

Autor: N. Deianova, S. el Manouni el Hassani, E. A. Struijs, E. E. W. Jansen, A. Bakkali, M. A. van de Wiel, W. P. de Boode, C. V. Hulzebos, A. H. van Kaam, B. W. Kramer, E. d’Haens, D. C. Vijlbrief, M. M. van Weissenbruch, W. J. de Jonge, M. A. Benninga, H. J. Niemarkt, N. K. H. de Boer, T. G. J. de Meij

Publikováno v: Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022)

Abstract Infants developing necrotizing enterocolitis (NEC) have a different metabolomic profile compared to controls. The potential of specific metabolomics, i.e. amino acids and amino alcohols (AAA), as early diagnostic biomarkers for NEC is largel

Externí odkaz: https://doaj.org/article/ffeaf147f89e4e228b29f2cf2cb7447f

Variability of core microbiota in newly diagnosed treatment-naïve paediatric inflammatory bowel disease patients.

Autor: T G J de Meij, E F J de Groot, C F W Peeters, N K H de Boer, C M F Kneepkens, A Eck, M A Benninga, P H M Savelkoul, A A van Bodegraven, A E Budding

Publikováno v: PLoS ONE, Vol 13, Iss 8, p e0197649 (2018)

BACKGROUND & AIMS:Intestinal microbiota is considered to play a crucial role in the aetiology of inflammatory bowel disease (IBD). We aimed to describe faecal microbiota composition and dynamics in a large cohort of children with de novo (naïve) IBD

Externí odkaz: https://doaj.org/article/d87d2d68e0ae46c09f8fd401e7c27326

The influence of prenatal and intrapartum antibiotics on intestinal microbiota colonisation in infants: A systematic review

Autor: T.H. Dierikx, R.E. de Vries, Marc A. Benninga, T. G. J. de Meij, J. van Limbergen, D.H. Visser, N. K. H. de Boer, A. H. van Kaam

Publikováno v: Dierikx, T H, Visser, D H, Benninga, M A, van Kaam, A H L C, de Boer, N K H, de Vries, R, van Limbergen, J & de Meij, T G J 2020, ' The influence of prenatal and intrapartum antibiotics on intestinal microbiota colonisation in infants : A systematic review ', Journal of Infection, vol. 81, no. 2, pp. 190-204 . https://doi.org/10.1016/j.jinf.2020.05.002

Objectives The intestinal microbiota develops in early infancy and is essential for health status early and later in life. In this review we focus on the effect of prenatal and intrapartum maternally administered antibiotics on the infant intestinal

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d710157bcdfa41aecdfacc53afdf0888
https://doi.org/10.1016/j.jinf.2020.05.002

Diagnostic accuracy of urinary intestinal fatty acid binding protein in detecting colorectal anastomotic leakage

Autor: T. G. J. de Meij, N. K. H. de Boer, Victor D. Plat, A. C. Jongen, D. A. van Dam, J. J. C. Tersteeg, Freek Daams, D. J. A. Sonneveld, Huib A. Cense, Rogier M P H Crolla, Karin Nielsen, Jurriaan B. Tuynman, J. P. M. Derikx

Publikováno v: Techniques in coloproctology, 24(5), 449-454. Springer
Techniques in coloproctology, 24(5), 449-454. Springer-Verlag Italia
Plat, V D, Derikx, J P M, Jongen, A C, Nielsen, K, Sonneveld, D J A, Tersteeg, J J C, Crolla, R M P H, van Dam, D A, Cense, H A, de Meij, T G J, Tuynman, J B, de Boer, N K H & Daams, F 2020, ' Diagnostic accuracy of urinary intestinal fatty acid binding protein in detecting colorectal anastomotic leakage ', Techniques in Coloproctology, vol. 24, no. 5, pp. 449-454 . https://doi.org/10.1007/s10151-020-02163-3
Techniques in Coloproctology, 24(5), 449-454. Springer-Verlag Italia

Background: Anastomotic leakage (AL) remains a severe complication following colorectal surgery, having a negative impact on both short- and long-term outcomes. Since timely detection could enable early intervention, there is a need for the developme

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f7f733e52def8a9ea0efc0a58bf3661
https://doi.org/10.1007/s10151-020-02163-3

DOP77 Ustekinumab is associated with better effectiveness outcomes when compared with vedolizumab in Crohn’s disease patients with prior anti-TNF failure: comparative effectiveness study from the ICC Registry

Autor: Nidhi Srivastava, M Löwenberg, R West, Colitis (Icc), D. de Jong, Bas Oldenburg, Biemans drs, Frank Hoentjen, A van der Meulen de Jong, G Dijkstra, Alexander Bodelier, N. K. H. de Boer, J. van der Woude, Jochen Jansen, Marie J. Pierik, Jeoffrey J L Haans, A C de Vries

Publikováno v: Journal of Crohn's and Colitis. 14:S114-S116

Background Both vedolizumab and ustekinumab can be considered for the treatment of Crohn’s disease (CD) when anti-TNF treatment fails. However, head-to-head trials are currently not available or planned in the near future. The aim of this study was

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7e34d2d014bdd57ec00ae969abc99cd8
https://doi.org/10.1093/ecco-jcc/jjz203.116